What is Curebase?
Curebase is revolutionizing clinical research by enabling physicians to conduct trials within their local communities, thereby improving patient access and accelerating the delivery of medical innovations. Leveraging advanced clinical software and remote study management, Curebase is fundamentally reshaping the landscape of clinical trials and research from its headquarters in San Francisco, California. Founded in 2017, the company's mission is to enhance human wellbeing by making clinical studies more efficient and accessible.
How much funding has Curebase raised?
Curebase has raised a total of $55M across 2 funding rounds:
Series A
$15M
Series B
$40M
Series A (2021): $15M with participation from GGV Capital, Bold Capital, and Xfund
Series B (2022): $40M led by World Innovation Lab, BOLD Capital Group, Acrew Capital, GGV Capital, Positive Sum, Industry Ventures, and Xfund
Key Investors in Curebase
World Innovation Lab
World Innovation Lab is an entity that has participated in Curebase's Series B funding round. Further details on their specific investment focus are not provided.
BOLD Capital Group
BOLD Capital Group is a venture capital firm specializing in early-stage technology platforms, including healthcare, and provides advisory services for capital raising and strategic planning. They participated in Curebase's Series B financing.
Acrew Capital
Acrew Capital is a venture capital firm that partners with early-stage to growth-stage companies, focusing on deep conviction and long-term relationships. They were part of Curebase's Series B funding round.
What's next for Curebase?
The substantial enterprise-level funding and recent strategic investment indicate Curebase is poised for significant scaling and further technological development. This capital infusion is expected to fuel the expansion of its innovative platform, enabling broader adoption of its community-centric clinical trial model. Curebase's strategic financing suggests a strong market validation and positions the company to further solidify its leadership in transforming the efficiency and accessibility of medical research.
See full Curebase company page
